Apellis Pharmaceuticals, Inc.: key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2025)
- $1.0B
- Net Income/Loss (FY2025)
- $22.4M
- Total Assets (FY2025)
- $1.1B
- Total Equity (FY2025)
- $370.1M
- Cash Flows from Operating Activities (FY2025)
- $45.3M
Source: Apellis Pharmaceuticals, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
